BCTX

BriaCell Therapeutics Corp · NASDAQ

Sector Health Technology
Industry Biotechnology
Website briacell.com
Employees(FY) 16
ISIN CA1079301091

Performance

+52.12%

+39.71%

+40.93%

-34.32%

-81.03%

YTD

-79.25%

Profile

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Advanced Technical Analysis

Technical Analysis of BCTX 2024-12-02

The stock exhibits a strong bullish sentiment with a Moving Average Score of 83, indicating robust upward momentum, while the Technical Score of 70 further supports this positive outlook. However, the Oscillators Score of 56 suggests a more neutral stance, indicating potential consolidation or a pause in the upward trend.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of BCTX

Stock Rank

Recent News & Updates

2024-12-01 21:18
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend(Prnewswire)
2024-12-01 18:50
BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer(Globenewswire)
2024-11-25 18:50
BriaCell 2024 SABCS Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer(Globenewswire)
2024-11-24 18:50
BriaCell Provides Update to its Board of Directors(Globenewswire)
2024-11-20 18:50
BriaCell Announces First Patient Dosed with Bria-OTS in Metastatic Breast Cancer Study(Globenewswire)
2024-11-07 18:50
BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference(Globenewswire)
2024-11-03 18:50
BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium , December 10 13(Globenewswire)
2024-10-21 19:50
BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data(Globenewswire)
2024-10-14 19:50
BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study(Globenewswire)
2024-10-02 04:05
BriaCell Therapeutics Announces Closing of $5 Million Offering(Globenewswire)
2024-10-01 02:05
BriaCell Therapeutics Announces $5 Million Offering(Globenewswire)
2024-09-30 19:50
BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with "Eye-Bulging" Tumor(Globenewswire)
2024-09-17 19:50
BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients(Globenewswire)
2024-09-12 04:05
BriaCell Therapeutics Announces Closing of $8.5 Million Offering(Globenewswire)
2024-09-11 00:09
BriaCell Therapeutics Announces $8.5 Million Offering(Globenewswire)
2024-09-10 19:50
BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast Cancer(Globenewswire)
2024-09-09 19:50
BriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+ for Prostate Cancer(Globenewswire)
2024-09-08 19:50
BriaCell Announces Presentation at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting(Globenewswire)
2024-07-17 19:56
BriaCell Quadruples Progression Free Survival (PFS) in Patient with Eye-Bulging Metastatic Breast Cancer(Globenewswire)
2024-06-14 09:52
BCTX Stock Earnings: BriaCell Therapeutics Beats EPS for Q3 2024(Investorplace)
2024-06-02 20:00
BriaCell Presents Clinical Efficacy Data at ASCO 2024(Globenewswire)
2024-05-29 20:00
BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS in Advanced Metastatic Breast Cancer(Globenewswire)
2024-05-27 20:00
BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS First in Human Study(Globenewswire)
2024-05-27 19:27
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday(Investorplace)
2024-05-23 20:00
BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024(Globenewswire)
2024-05-20 19:39
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday(Investorplace)
2024-05-17 04:33
BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering(Globenewswire)
2024-05-14 20:00
BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering(Globenewswire)
2024-04-23 20:00
BriaCell Announces Oral and Poster Presentations at ASCO 2024(Globenewswire)
2024-04-09 20:00
BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+ and Bria-PROS+ Clinical Candidates for Breast and Prostate Cancer(Globenewswire)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.